Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 18 EP applications David William Cottam has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13004775

Dose counter for a metered-dose inhaler

IPC classification:
A61M 15/00, G06M 1/04
Agent:
Patent Boutique LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12797884

NASAL FORMULATION

IPC classification:
A61M 15/08, A61K 31/573, A61K 31/55, A61K 9/12, A61K 9/00, A61P 27/14
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
David William Cottam, Teva Global Patent Group
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12806382

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61K 31/46, A61K 9/12, A61K 9/00, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
PATENT GRANTED
EP13005367

Dose counter for a metered-dose inhaler

IPC classification:
A61M 15/00, G06M 1/04
Agent:
David William Cottam, Teva Global Patent Group
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12805442

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61K 31/46, A61K 9/12, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
David William Cottam, Teva UK Ltd.
Agent:
David William Cottam, Teva Global Patent Group
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
The patent has been granted
EP13158407

Re-useable injector device for syringe

IPC classification:
A61M 5/20
Applicant:
Teva Pharmaceutical Industries Ltd.
Agent:
David William Cottam, Teva UK Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13158439

Re-useable injector device for syringe

IPC classification:
A61M 5/24
Applicant:
Teva Pharmaceutical Industries Ltd.
Agent:
David William Cottam, Teva UK Ltd.
Agent:
David William Cottam, Teva Global Patent Group
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14001800

Heat sterilization of glucocorticoidsteriods

IPC classification:
A61K 9/10
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
The patent has been granted
EP15164095

NASAL SPRAY DEVICE

IPC classification:
A61M 15/08
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
James Edward George Anderson, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
EXAMINATION REQUESTED
EP13867956

METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN

IPC classification:
A61K 9/14
Agent:
D Young & Co LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
GRANT OF PATENT INTENDED
EP14714899

INHALATION DEVICE, CONTROL METHOD AND COMPUTER PROGRAM

IPC classification:
A61M 15/00
Agent:
AWA
Agent:
David William Cottam, Teva UK Ltd.
Status:
EXAMINATION IN PROGRESS
EP14773911

NEBULIZER FOR INFANTS AND RESPIRATORY COMPROMISED PATIENTS

IPC classification:
A61M 15/02, A61M 11/06, A61M 11/02
Agent:
James Edward George Anderson, Elkington and Fife LLP
Agent:
D Young & Co LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
GRANT OF PATENT INTENDED
EP13002039

Tobramycin formulation

IPC classification:
A61K 9/00, A61K 9/72, A61K 31/7036, A61K 9/08, A61K 47/12
Agent:
David William Cottam, Teva UK Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779089

NASAL SPRAY DEVICE

IPC classification:
B05B 1/00, A61M 15/08, A61M 15/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Peter Hale, Kilburn & Strode LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP12196725

An inhalable medicament comprising tiotropium

IPC classification:
A61P 11/00, A61K 9/12, A61K 9/00, A61K 31/46
Agent:
David William Cottam, Teva UK Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP16153497

DRY-POWDER MEDICAMENT

IPC classification:
A61K 31/31, A61K 31/00, A61K 9/00
Agent:
Patent Boutique LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
GRANT OF PATENT INTENDED
EP12196726

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61P 11/08, A61M 15/00, A61M 11/04, A61K 9/12, A61K 9/00, A61K 47/12, A61K 47/10, A61K 31/46
Agent:
David William Cottam, Teva UK Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP11796916

INHALERS WITH HOUSING CAPS FOR INHALERS

IPC classification:
A61M 15/00
Applicant:
Teva Pharmaceutical Industries Ltd.
Agent:
David William Cottam, Teva UK Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED

Please Sign in to use this feature